Alliancebernstein L.P. Increases Holdings in Bath & Body Works, Inc. $BBWI

Key Points

• Alliancebernstein L.P. increased its holdings in Bath & Body Works, Inc. by 4.7%, owning 5,422,058 shares valued at approximately $164.4 million.
• Bath & Body Works reported earnings of $0.37 per share, meeting analyst expectations, with quarterly revenue totaling $1.55 billion, down 0.8% year-over-year.
• The company's recent quarterly dividend announced is $0.20 per share, representing an annualized yield of 2.5%.

Alliancebernstein L.P. lifted its position in shares of Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 4.7% during the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 5,422,058 shares of the company's stock after purchasing an additional 243,611 shares during the period. Alliancebernstein L.P. owned about 2.55% of Bath & Body Works worth $164,397,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also made changes to their positions in the company. SVB Wealth LLC purchased a new position in shares of Bath & Body Works during the first quarter worth about $35,000. Golden State Wealth Management LLC grew its holdings in shares of Bath & Body Works by 94.7% during the first quarter. Golden State Wealth Management LLC now owns 1,320 shares of the company's stock worth $40,000 after buying an additional 642 shares during the last quarter. UMB Bank n.a. grew its holdings in shares of Bath & Body Works by 65.9% during the first quarter. UMB Bank n.a. now owns 1,501 shares of the company's stock worth $46,000 after buying an additional 596 shares during the last quarter. Ancora Advisors LLC purchased a new position in shares of Bath & Body Works during the fourth quarter worth about $67,000. Finally, GKV Capital Management Co. Inc. purchased a new position in shares of Bath & Body Works during the first quarter worth about $69,000. Institutional investors and hedge funds own 95.14% of the company's stock.

Wall Street Analyst Weigh In

BBWI has been the topic of a number of research reports. Wells Fargo & Company raised their price target on Bath & Body Works from $40.00 to $44.00 and gave the stock an "overweight" rating in a report on Wednesday, May 14th. JPMorgan Chase & Co. raised their price target on Bath & Body Works from $40.00 to $46.00 and gave the stock an "overweight" rating in a report on Monday, July 28th. Telsey Advisory Group reissued an "outperform" rating and set a $38.00 price target on shares of Bath & Body Works in a report on Thursday, August 28th. Piper Sandler set a $39.00 price target on Bath & Body Works and gave the stock an "overweight" rating in a report on Thursday, May 15th. Finally, Wall Street Zen lowered Bath & Body Works from a "buy" rating to a "hold" rating in a report on Saturday, August 9th. Twelve analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $41.62.

Bath & Body Works Stock Performance

BBWI traded down $0.34 during trading on Wednesday, reaching $27.89. The company's stock had a trading volume of 1,764,461 shares, compared to its average volume of 5,281,625. Bath & Body Works, Inc. has a 52-week low of $24.94 and a 52-week high of $41.87. The company's fifty day moving average price is $30.63 and its 200-day moving average price is $30.36. The company has a market capitalization of $5.75 billion, a price-to-earnings ratio of 8.28, a price-to-earnings-growth ratio of 0.98 and a beta of 1.49.

Bath & Body Works (NYSE:BBWI - Get Free Report) last announced its quarterly earnings data on Thursday, August 28th. The company reported $0.37 earnings per share for the quarter, meeting analysts' consensus estimates of $0.37. Bath & Body Works had a negative return on equity of 48.43% and a net margin of 9.88%.The company had revenue of $1.55 billion for the quarter, compared to analyst estimates of $1.55 billion. During the same quarter in the previous year, the company earned $0.37 EPS. The firm's revenue for the quarter was down .8% compared to the same quarter last year. Bath & Body Works has set its Q3 2025 guidance at 0.370-0.45 EPS. FY 2025 guidance at 3.350-3.600 EPS. Equities analysts predict that Bath & Body Works, Inc. will post 3.3 earnings per share for the current year.

Bath & Body Works Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, September 5th. Shareholders of record on Friday, August 22nd were issued a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a yield of 2.9%. The ex-dividend date of this dividend was Friday, August 22nd. Bath & Body Works's payout ratio is currently 23.74%.

About Bath & Body Works

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.